PETS — PETMED EXPRESS INC

Nasdaq · Consumer Staples · Drug Retail · CIK 1040130 ·
Last close
$2.23
Market Cap
$47.72M
52W High
$2.82
52W Low
$2.12
ADV30
79,542
Next earnings
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2025 40,660,000 9,456,000 -10,469,000 -10,553,000 87,965,000 26,914,000 55,199,000
Sep 2025 44,364,000 12,415,000 -8,380,000 -8,520,000 100,301,000 36,098,000 57,237,000
Jun 2025 51,180,000 14,403,000 -6,874,000 -34,152,000 109,839,000 41,127,000 58,293,000
Dec 2024 51,961,000 16,131,000 -450,000 -707,000 144,795,000 50,101,000 48,611,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-24,816,000
Investing CF
$-4,672,000
Financing CF
$-262,000
CapEx
$-5,958,000
Dividends Paid
$-25,000
Buybacks
EPS Diluted TTM
$-2.59
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$13,320,000
Inventory
$12,206,000
Receivables
$1,559,000
ST Investments
EBIT TTM
$-26,173,000
Pretax Income TTM
$-53,438,000
Interest Exp TTM
Analysts
1

Yahoo Snapshot (yfinance, live)

Total Revenue
$186,964,000
EBITDA
$-28,806,000
Free Cash Flow
$-18,373,376
Enterprise Value
$19,058,810
Total Cash
$26,914,000
Total Debt
$652,000
Shares Out
21,400,495
Trailing EPS
$-3.10
Book Value
$1.53
ROE
-100.6%
ROA
-20.3%
Div Yield

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Mar 2025
Mar 2024 274,095,000 -8,162,000 -7,464,000 169,884,000 73,153,000 4,317,000
Mar 2023 247,569,000 6,051,000 5,140,000 167,478,000 57,512,000 27,803,000

TTM Snapshot

Revenues TTM
$241,542,000
NetIncome TTM
$-367,000
OpCashFlow TTM
$0
Assets (Latest)
$148,700,000
Forward EPS
$-0.03

Peers — same industry

TickerNameMarket CapLastDaily %
YI 111, Inc. $27.70M $5.33
AIXN AiXin Life International, Inc. $6.45M $0.26
CANN TREES Corp (Colorado) $1.85M $0.02
GRDN Guardian Pharmacy Services, Inc. $1.92B $38.59
RDGT Ridgetech Inc. $1.16M $1.29

News headlines (Yahoo Finance, 1h cache)

PetMeds announces strategic partnership with Rural King to launch pet pharmacy offering across retail and digital channels
2026-04-22 20:05 · Yahoo
Promising Penny Stocks To Consider In February 2026
2026-02-17 12:05 · Yahoo
Diveroli Investment Group Files 13D in PetMed Express, Highlights Strategic Value, Asset Floor, and Multiple Takeover Pathways
2026-02-12 11:30 · Yahoo
PetMed: Fiscal Q2 Earnings Snapshot
2025-12-19 22:02 · Yahoo
PetMed: Fiscal Q1 Earnings Snapshot
2025-12-19 21:48 · Yahoo
Cardone Ventures Announces Unsolicited $4.25 Per Share All-Cash Proposal to Acquire PetMed Express
2025-12-16 17:04 · Yahoo
December 2025 Penny Stocks Worth Watching
2025-12-12 18:05 · Yahoo
Top Midday Gainers
2025-12-11 18:54 · Yahoo
BC-Most Active Stocks
2025-12-11 15:30 · Yahoo
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
2025-12-11 14:45 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.